A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

In mice with Alzheimer's, the course of menthol for a six-month-long period was enough to stop the cognitive abilities and ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

Alzheimer’s patients are set to find out whether a new drug could become available in the UK as health regulators are poised ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

A study suggests that menopausal hormone therapy (MHT) might have moderate effects on brain health, but this depends on past ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

Alzheimer’s disease is the leading cause of dementia in the UK. It’s a complex, challenging, and devastating condition that causes a gradual decline in a person’s cognition, including memory and ...

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

A study in Indiana found that older adults in low-income clinics often experience memory problems that go undetected, with ...

MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...